Abstract #3690

First-in-woman study of in vivo breast cancer metabolism using hyperpolarized [1-13C] pyruvate

Kristin L Granlund^1,2, Elizabeth A Morris³, Hebert A Vargas³, Serge K Lyashchenko⁴, Phillip J DeNoble⁴, Virgilio A Sacchini⁵, Ramon A Sosa³, Matthew A Kennedy³, Duane Nicholson³, YanWei W Guo³, Albert P Chen⁶, James Tropp⁷, Hedvig Hricak^2,3, and Kayvan A Keshari^2,3

¹Radiology, Memorial Sloan Kettering, New York, NY, United States, ²Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, United States, ³Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States, ⁴Radiochemistry & Imaging Probes (RMIP) Core, Memorial Sloan Kettering Cancer Center, New York, NY, United States, ⁵Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States, ⁶GE Healthcare, Toronto, ON, Canada, ⁷GE Healthcare, Fremont, CA, United States

This is a first-in-woman study of hyperpolarized (HP) pyruvate to study in vivo cancer metabolism. A patient with biopsy-proven breast cancer has been scanned with a 2D dynamic hyperpolarized pyruvate protocol. This study aims to evaluate the feasibility and repeatability of HP breast cancer imaging. HP pyruvate imaging may be useful for evaluating treatment response before and after targeted as well as chemo-therapy or radiation treatment.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.